Choate Investment Advisors Novartis Ag Transaction History

Choate Investment Advisors

$3.89 Billion
Q3 2024

A detailed history of Choate Investment Advisors transactions in Novartis Ag stock. As of the latest transaction made, Choate Investment Advisors holds 32,773 shares of NVS stock, worth $3.18 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

32,773

Previous 35,197 6.89%

Holding current value

$3.18 Million

Previous $3.75 Million 0.59%

% of portfolio

0.1%

Previous 0.1%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$106.13 - $120.89 $257,259 - $293,037	-2,424 Reduced 6.89%	32,773 $3.77 Million
Q2 2024 Aug 08, 2024	SELL	$92.57 - $107.37 $47,210 - $54,758	-510 Reduced 1.43%	35,197 $3.75 Million
Q1 2024 May 07, 2024	SELL	$95.27 - $108.47 $2,858 - $3,254	-30 Reduced 0.08%	35,707 $3.45 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $1.95 Million - $2.15 Million	21,143 Added 144.87%	35,737 $3.61 Million
Q3 2023 Oct 30, 2023	BUY	$94.73 - $105.13 $210,016 - $233,073	2,217 Added 17.91%	14,594 $1.49 Million
Q2 2023 Aug 01, 2023	BUY	$92.52 - $104.91 $46,630 - $52,874	504 Added 4.24%	12,377 $1.25 Million
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $152,157 - $186,335	2,014 Added 20.43%	11,873 $1.08 Million
Q2 2022 Aug 11, 2022	BUY	$80.52 - $93.75 $602,048 - $700,968	7,477 Added 313.9%	9,859 $833,000
Q4 2021 Feb 07, 2022	BUY	$79.7 - $88.13 $189,845 - $209,925	2,382 New	2,382 $208,000
Q3 2021 Nov 04, 2021	SELL	$81.78 - $95.14 $340,777 - $396,448	-4,167 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$85.24 - $94.15 $1,278 - $1,412	15 Added 0.36%	4,167 $380,000
Q1 2021 May 07, 2021	BUY	$83.5 - $98.47 $138,192 - $162,967	1,655 Added 66.28%	4,152 $355,000
Q4 2020 Feb 08, 2021	BUY	$78.07 - $94.43 $11,320 - $13,692	145 Added 6.16%	2,497 $236,000
Q2 2020 Jul 23, 2020	BUY	$80.93 - $91.1 $190,347 - $214,267	2,352 New	2,352 $205,000
Q1 2020 May 07, 2020	SELL	$70.67 - $99.01 $166,215 - $232,871	-2,352 Closed	0 $0
Q4 2019 Jan 28, 2020	SELL	$84.35 - $95.37 $1,433 - $1,621	-17 Reduced 0.72%	2,352 $223,000
Q3 2019 Nov 13, 2019	BUY	$85.54 - $94.26 $14,199 - $15,647	166 Added 7.54%	2,369 $206,000
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $25,032 - $30,809	-332 Reduced 13.1%	2,203 $201,000
Q1 2019 Apr 29, 2019	SELL	$75.32 - $86.15 $6,025 - $6,892	-80 Reduced 3.06%	2,535 $244,000
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $192,620 - $214,482	2,615 New	2,615 $224,000
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $203,698 - $235,619	-3,043 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$64.91 - $73.36 $16,552 - $18,706	255 Added 9.15%	3,043 $230,000
Q1 2018 May 04, 2018	SELL	$70.39 - $84.15 $422 - $504	-6 Reduced 0.21%	2,788 $0
Q4 2017 Feb 14, 2018	SELL	$72.33 - $77.64 $76,380 - $81,987	-1,056 Reduced 27.43%	2,794 $0
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $285,439 - $297,489	3,850	3,850 $0

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Choate Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Choate Investment Advisors with notifications on news.

Account

Choate Investment Advisors Novartis Ag Transaction History